TelyRx Holdings Inc. faced a significant decline in its stock value, raising concerns among investors.
In yesterday’s trading session, TelyRx Holdings Inc. saw a sharp drop, closing down 10.64% at CA$2.10. This decline is particularly striking given the company's recent financial performance, which had shown signs of growth. However, the market's reaction indicates that investors are cautious about whether this growth can be sustained.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$62.49M
52W high
$4.25
52W low
$2.00
1W change
-14.29%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 185.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+185.7% Upside
Current Price
C$2.10
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
79.6%
Annualized
90-Day Vol
97.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.76
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.98 | C$1.50 – C$2.60 |
| 60 trading days | C$1.86 | C$1.26 – C$2.75 |
| 90 trading days | C$1.76 | C$1.09 – C$2.83 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should stay alert and consider the volatility in TelyRx's stock, especially in light of its recent performance and the absence of new positive news.
10.64% Decline in TelyRx Holdings Inc. Stock
TelyRx's stock fell significantly, reflecting investor concerns over its financial sustainability despite recent revenue increases.
Bull case
TelyRx has reported increasing revenues in its recent quarterly results, which suggests potential for future growth if the company can keep this momentum going.
Bear case
The recent stock drop highlights investor skepticism about TelyRx's ability to turn revenue growth into lasting profitability, especially given its net losses.
Market Reaction
Advertisement
The 10.64% drop in TelyRx's stock price mirrors a broader market sentiment that is wary of the company's ability to sustain its recent revenue growth. Investors are likely reacting to the lack of positive news following its recent quarterly earnings announcements. Despite reporting increased revenues in Q2 2026, the net losses from previous quarters have raised concerns.
Financial Performance Overview
TelyRx's financial results have shown improvement, with revenues increasing from CA$9.3 million in Q2 2025 to CA$22.7 million in Q2 2026. However, the company still faces challenges, including a profit margin of -19.36%. This ongoing struggle with profitability may have contributed to investor hesitation, leading to the stock's significant drop yesterday. For more details, you can check TelyRx's second quarter results.
Looking Ahead
As TelyRx navigates its growth trajectory, investors will be closely monitoring upcoming financial reports and any strategic initiatives the company may undertake. The market's reaction to these developments will be crucial in determining the stock's future performance. For further insights, refer to TelyRx's first quarter results and year-end results.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
